Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Roundtable Top Picks of the Week
- FED Front & Center Again
- RTI: Sector Strength Charts - Where's the Opportunity Now?
- Surging Financial ETFs Beating the Market
- Utility Industry Stock Outlook - June 2013
- 3 Japanese Stocks to Buy Now
- Your Next Stock Should Be Making New Highs
- Anatomy of Success: Stoneridge (SRI)
- RTI: What Will the Fed Do Wednesday?
- AWS 6/18: Can the Fed Afford to Keep the Suspense?
- PFP 6/18: Wednesday Fed Watch
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 06/18/2013
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Brain Resource Again Recognized As Leader in Brain Training
By Brian Marckx, CFA
SharpBrains, the leading independent research firm covering the emerging field of brain training and brain health, again recognized Brain Resource as one of the top five market leaders in brain health. Along with CogState, Emotiv, Lumos Labs and NeuroSky, SharpBrains (www.sharpbrains.com) named Brain Resource as a pioneer and leader in brain health in its 211-page report entitled Transforming Health with Digital Tools to Assess, Monitor and Enhance Cognition Across the Lifespan: The Digital Brain Health Market 2012-2020.
The report, which was released on Monday (12/4/12) and per SharpBrains took about one-year to prepare, also points to Brain Resource's MyBrainSolutions as one of the products that is helping to transform brain health and, ultimately, health overall. We cover Brain Resource (OTC Markets:(BRRZY) / (ASX:BRC.AX) with an Outperform rating and have a $3.50 price target on the ADRs. See here for our full 19 page report on the company.
The SharpBrains report also includes growth estimates of the brain health market, noting that the digital brain health marketplace has already experienced rapid growth since 2005 and this rate is expected to continue for at least the next 8 years. SharpBrains estimates that this market was worth about $1 billion in 2012, up from just $210 million in 2005. By the year 2020 they peg this market to grow to as much as $6 billion (25% CAGR from 2005), driven in part by brain health solutions becoming mainstream, not only with healthcare providers but also among individual consumers.
For additional research on small-cap stocks, please visit scr.zacks.com.
To become a subscriber to Zacks SCR and receive SCR blogs and research reports emailed directly to your inbox, please visit our Subscribe page.
Get the full on BRRZY - FREE